Alternate-Day Buprenorphine Administration. Phase I
Alternate-Day Buprenorphine Administration. Phase I
The purpose of this study is to determine if two times a subject's daily maintenance dose will hold for 48 hours without changes in agonist and antagonist effects.
Please contact site for information.